In an attempt to further the work carried out by Patterson et al. on syndecan-3 chemokine binding on ECs in the RA synovium [28, 29], we tested the binding affinities of clinically relevant chemokines to commercially sourced soluble syndecan-3 using IFT. This evidence concerns the gene SDC3 and rheumatoid arthritis.